Please wait while the formulary information is being retrieved.
Drug overview for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
Generic name: ceftolozane sulfate/tazobactam sodium (sef-TOL-oh-zane/TAZ-oh-BAK-tam)
Drug class: Beta-Lactams
Therapeutic class: Anti-Infective Agents
Ceftolozane sulfate and tazobactam sodium is a fixed combination of ceftolozane (a fifth generation cephalosporin) and tazobactam (a beta-lactamase inhibitor); tazobactam inactivates certain bacterial beta-lactamases and expands ceftolozane's spectrum of activity against some bacteria that produce these beta-lactamases.
No enhanced Uses information available for this drug.
Generic name: ceftolozane sulfate/tazobactam sodium (sef-TOL-oh-zane/TAZ-oh-BAK-tam)
Drug class: Beta-Lactams
Therapeutic class: Anti-Infective Agents
Ceftolozane sulfate and tazobactam sodium is a fixed combination of ceftolozane (a fifth generation cephalosporin) and tazobactam (a beta-lactamase inhibitor); tazobactam inactivates certain bacterial beta-lactamases and expands ceftolozane's spectrum of activity against some bacteria that produce these beta-lactamases.
No enhanced Uses information available for this drug.
DRUG IMAGES
- ZERBAXA 1.5 GRAM VIAL
The following indications for ZERBAXA (ceftolozane sulfate/tazobactam sodium) have been approved by the FDA:
Indications:
Bacteroides complicated appendicitis
Complicated appendicitis
Complicated bacterial infection of urinary tract
Complicated bacterial peritonitis
Complicated Bacteroides peritonitis
Complicated E. coli peritonitis
Complicated E. coli UTI
Complicated Enterobacter peritonitis
Complicated Klebsiella peritonitis
Complicated Proteus peritonitis
Complicated Proteus UTI
Complicated Pseudomonas aeruginosa peritonitis
Complicated Streptococcus peritonitis
Complicated UTI with Pseudomonas aeruginosa
Diverticulitis of gastrointestinal tract
E. coli complicated appendicitis
Intra-abdominal abscess
Intra-abdominal Bacteroides abscess
Intra-abdominal E. coli abscess
Intra-abdominal Klebsiella abscess
Klebsiella complicated appendicitis
Klebsiella complicated UTI
Nosocomial bacterial pneumonia
Pseudomonas aeruginosa complicated appendicitis
Streptococcus complicated appendicitis
Ventilator-associated bacterial pneumonia
Professional Synonyms:
Abdominal abscess due to Bacteroides
Abdominal abscess due to Escherichia coli
Abdominal abscess due to Klebsiella species
Abdominal abscess
Complicated appendicitis due to bacteroides species
Complicated appendicitis due to E. coli
Complicated appendicitis due to Escherichia coli
Complicated appendicitis due to Klebsiella species
Complicated appendicitis due to Pseudomonas aeruginosa
Complicated appendicitis due to Streptococcus species
Complicated bacterial urinary tract infection
Complicated peritonitis due to Bacteroides species
Complicated peritonitis due to E. coli
Complicated peritonitis due to Enterobacter species
Complicated peritonitis due to Escherichia coli
Complicated peritonitis due to Klebsiella species
Complicated peritonitis due to Proteus species
Complicated peritonitis due to Pseudomonas aeruginosa
Complicated peritonitis due to Streptococcus species
Complicated Pseudomonas aeruginosa urinary tract infection
Complicated urinary tract infection due to Escherichia coli
Complicated urinary tract infection due to Klebsiella
Complicated urinary tract Proteus species infection
Complicated UTI due to E. coli
Complicated UTI due to Klebsiella species
Complicated UTI due to Proteus species
Complicated UTI due to Pseudomonas aeruginosa
Diverticulitis of GI tract
Hospital-acquired bacterial pneumonia
Intra-abdominal abscess due to E. coli
Ventilator-acquired bacterial pneumonia
Indications:
Bacteroides complicated appendicitis
Complicated appendicitis
Complicated bacterial infection of urinary tract
Complicated bacterial peritonitis
Complicated Bacteroides peritonitis
Complicated E. coli peritonitis
Complicated E. coli UTI
Complicated Enterobacter peritonitis
Complicated Klebsiella peritonitis
Complicated Proteus peritonitis
Complicated Proteus UTI
Complicated Pseudomonas aeruginosa peritonitis
Complicated Streptococcus peritonitis
Complicated UTI with Pseudomonas aeruginosa
Diverticulitis of gastrointestinal tract
E. coli complicated appendicitis
Intra-abdominal abscess
Intra-abdominal Bacteroides abscess
Intra-abdominal E. coli abscess
Intra-abdominal Klebsiella abscess
Klebsiella complicated appendicitis
Klebsiella complicated UTI
Nosocomial bacterial pneumonia
Pseudomonas aeruginosa complicated appendicitis
Streptococcus complicated appendicitis
Ventilator-associated bacterial pneumonia
Professional Synonyms:
Abdominal abscess due to Bacteroides
Abdominal abscess due to Escherichia coli
Abdominal abscess due to Klebsiella species
Abdominal abscess
Complicated appendicitis due to bacteroides species
Complicated appendicitis due to E. coli
Complicated appendicitis due to Escherichia coli
Complicated appendicitis due to Klebsiella species
Complicated appendicitis due to Pseudomonas aeruginosa
Complicated appendicitis due to Streptococcus species
Complicated bacterial urinary tract infection
Complicated peritonitis due to Bacteroides species
Complicated peritonitis due to E. coli
Complicated peritonitis due to Enterobacter species
Complicated peritonitis due to Escherichia coli
Complicated peritonitis due to Klebsiella species
Complicated peritonitis due to Proteus species
Complicated peritonitis due to Pseudomonas aeruginosa
Complicated peritonitis due to Streptococcus species
Complicated Pseudomonas aeruginosa urinary tract infection
Complicated urinary tract infection due to Escherichia coli
Complicated urinary tract infection due to Klebsiella
Complicated urinary tract Proteus species infection
Complicated UTI due to E. coli
Complicated UTI due to Klebsiella species
Complicated UTI due to Proteus species
Complicated UTI due to Pseudomonas aeruginosa
Diverticulitis of GI tract
Hospital-acquired bacterial pneumonia
Intra-abdominal abscess due to E. coli
Ventilator-acquired bacterial pneumonia
The following dosing information is available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
FDA alerted healthcare professionals about the risk of medication errors with ceftolozane and tazobactam. There have been reports of errors occurring during preparation of IV solutions of the drug that resulted in administration of incorrect dosage (50% overdosage in some cases); the errors were due to confusion about how dosage of ceftolozane and tazobactam is expressed (total of the dosage of each of the 2 active components) and how drug strength was displayed on vial labels and carton packaging. To prevent such errors, vial labels and carton packaging have been revised to indicate the strength of the fixed combination as the total of the 2 active components.
Healthcare professionals should be aware that dosage of ceftolozane and tazobactam is expressed as the total (sum) of the dosage of each of the 2 active components (i.e., dosage of ceftolozane plus dosage of tazobactam). This dosage convention should be considered when prescribing, preparing, and dispensing ceftolozane and tazobactam. FDA urges healthcare professionals and patients to report any medication errors and adverse effects involving the drug to the FDA MedWatch program.
Ceftolozane and tazobactam is a fixed combination containing a 2:1 ratio of ceftolozane to tazobactam.
The ceftolozane component is provided as ceftolozane sulfate (dosage of this component is expressed in terms of ceftolozane); the tazobactam component is provided as tazobactam sodium (dosage of this component is expressed in terms of tazobactam).
Dosage of the fixed combination of ceftolozane and tazobactam is expressed in terms of the total of the ceftolozane and tazobactam content.
Each single-dose vial of ceftolozane and tazobactam contains a total of 1.5 g (i.e., 1 g of ceftolozane and 0.5 g of tazobactam).
Dosage of ceftolozane and tazobactam must be adjusted in adults with creatinine clearances of 50 mL/minute or less, including those undergoing hemodialysis. (See Table 2.)
Creatinine clearance should be monitored at least once daily in patients with changing renal function and dosage of ceftolozane and tazobactam adjusted accordingly.
Table 2. Ceftolozane and Tazobactam Dosage for Adults with Renal Impairment
Estimated Creatinine Clearance Recommended Dosage (mL/minute) 30-50 750 mg (ceftolozane 500 mg and tazobactam 250 mg) every 8 hours 15-29 375 mg (ceftolozane 250 mg and tazobactam 125 mg) every 8 hours End-stage renal disease on Single loading dose of 750 mg hemodialysis (ceftolozane 500 mg and tazobactam 250 mg) followed by maintenance dosage of 150 mg (ceftolozane 100 mg and tazobactam 50 mg) every 8 hours
On hemodialysis days, the dose should be administered as soon as possible after dialysis.
Dosage adjustments are not needed when ceftolozane and tazobactam is used in adults with hepatic impairment.
Dosage adjustments based solely on age are not needed when ceftolozane and tazobactam is used in geriatric patients. However, because geriatric patients are more likely to have decreased renal function and because dosage of ceftolozane and tazobactam needs to be adjusted based on renal impairment, dosage should be selected with caution and it may be useful to monitor renal function.
Healthcare professionals should be aware that dosage of ceftolozane and tazobactam is expressed as the total (sum) of the dosage of each of the 2 active components (i.e., dosage of ceftolozane plus dosage of tazobactam). This dosage convention should be considered when prescribing, preparing, and dispensing ceftolozane and tazobactam. FDA urges healthcare professionals and patients to report any medication errors and adverse effects involving the drug to the FDA MedWatch program.
Ceftolozane and tazobactam is a fixed combination containing a 2:1 ratio of ceftolozane to tazobactam.
The ceftolozane component is provided as ceftolozane sulfate (dosage of this component is expressed in terms of ceftolozane); the tazobactam component is provided as tazobactam sodium (dosage of this component is expressed in terms of tazobactam).
Dosage of the fixed combination of ceftolozane and tazobactam is expressed in terms of the total of the ceftolozane and tazobactam content.
Each single-dose vial of ceftolozane and tazobactam contains a total of 1.5 g (i.e., 1 g of ceftolozane and 0.5 g of tazobactam).
Dosage of ceftolozane and tazobactam must be adjusted in adults with creatinine clearances of 50 mL/minute or less, including those undergoing hemodialysis. (See Table 2.)
Creatinine clearance should be monitored at least once daily in patients with changing renal function and dosage of ceftolozane and tazobactam adjusted accordingly.
Table 2. Ceftolozane and Tazobactam Dosage for Adults with Renal Impairment
Estimated Creatinine Clearance Recommended Dosage (mL/minute) 30-50 750 mg (ceftolozane 500 mg and tazobactam 250 mg) every 8 hours 15-29 375 mg (ceftolozane 250 mg and tazobactam 125 mg) every 8 hours End-stage renal disease on Single loading dose of 750 mg hemodialysis (ceftolozane 500 mg and tazobactam 250 mg) followed by maintenance dosage of 150 mg (ceftolozane 100 mg and tazobactam 50 mg) every 8 hours
On hemodialysis days, the dose should be administered as soon as possible after dialysis.
Dosage adjustments are not needed when ceftolozane and tazobactam is used in adults with hepatic impairment.
Dosage adjustments based solely on age are not needed when ceftolozane and tazobactam is used in geriatric patients. However, because geriatric patients are more likely to have decreased renal function and because dosage of ceftolozane and tazobactam needs to be adjusted based on renal impairment, dosage should be selected with caution and it may be useful to monitor renal function.
Ceftolozane and tazobactam is administered by IV infusion.
DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
---|---|---|
ZERBAXA 1.5 GRAM VIAL | Maintenance | Adults infuse 1.5 gram over 1 hour(s) by intravenous route every 8 hours |
No generic dosing information available.
The following drug interaction information is available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
There are 1 contraindications.
These drug combinations generally should not be dispensed or administered to the same patient. A manufacturer label warning that indicates the contraindication warrants inclusion of a drug combination in this category, regardless of clinical evidence or lack of clinical evidence to support the contraindication.
Drug Interaction | Drug Names |
---|---|
Live Typhoid Vaccine/Antimicrobials SEVERITY LEVEL: 1-Contraindicated Drug Combination: This drug combination is contraindicated and generally should not be dispensed or administered to the same patient. MECHANISM OF ACTION: The antimicrobial may be active against the organism in the live-vaccine. Antimicrobial therapy may prevent the vaccine organism from replicating enough to trigger an immune response.(1) CLINICAL EFFECTS: Vaccination may be ineffective. PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Do not give oral typhoid vaccine until 72 hours after the last dose of antimicrobial. If possible, to optimize vaccine effectiveness, do not start antibacterial drugs for 72 hours after the last dose of oral typhoid vaccine. A longer interval should be considered for long-acting antimicrobials, such as azithromycin.(3) DISCUSSION: Because antimicrobial therapy may prevent sufficient vaccine-organism replication to generate an immune response, the manufacturer of live-attenuated typhoid vaccine and the Centers for Disease Control (CDC) state that the vaccine should not be administered to patients receiving antimicrobial therapy.(1-3) |
VIVOTIF |
There are 1 severe interactions.
These drug interactions can produce serious consequences in most patients. Actions required for severe interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration scheduling, and providing additional patient monitoring. Review the full interaction monograph for more information.
Drug Interaction | Drug Names |
---|---|
Fecal Microbiota Spores/Antibiotics SEVERITY LEVEL: 2-Severe Interaction: Action is required to reduce the risk of severe adverse interaction. MECHANISM OF ACTION: Fecal microbiota spores is a suspension of live bacterial spores, which may be compromised by concurrent use of antibiotics.(1) CLINICAL EFFECTS: Antibiotics may decrease the effectiveness of fecal microbiota spores.(1) PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: Antibiotics should not be used concurrently with fecal microbiota spores. Antibacterial treatment should be completed for 2 to 4 days before initiating treatment with fecal microbiota spores.(1) DISCUSSION: Antibiotics may compromise the effectiveness of fecal microbiota spores. |
VOWST |
There are 0 moderate interactions.
The following contraindication information is available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 4 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
Severe List |
---|
Chronic kidney disease stage 3B (moderate) GFR 30-44 ml/min |
Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
Chronic kidney disease stage 5 (failure) GFr<15 ml/min |
Clostridioides difficile infection |
There are 0 moderate contraindications.
The following adverse reaction information is available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 24 severe adverse reactions.
More Frequent | Less Frequent |
---|---|
Fever |
Anaphylaxis Anemia Atrial fibrillation Dyspnea Hypotension Increased alanine transaminase Increased aspartate transaminase Thrombocytosis |
Rare/Very Rare |
---|
Acute generalized exanthematous pustulosis Cerebrovascular accident Clostridioides difficile infection DRESS syndrome Hypersensitivity drug reaction Ileus Increased alkaline phosphatase Kidney disease with reduction in glomerular filtration rate (GFr) Paralytic ileus Seizure disorder Stevens-johnson syndrome Toxic epidermal necrolysis Urticaria Venous thrombosis Vulvovaginal candidiasis |
There are 25 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
Diarrhea Headache disorder Nausea Oral candidiasis |
Acute abdominal pain Constipation Hypokalemia Insomnia Skin rash Symptoms of anxiety Vomiting |
Rare/Very Rare |
---|
Abdominal distension Acute renal failure Angina Candidiasis Dizziness Dyspepsia Flatulence Fungal urinary tract infection Gastritis Hyperglycemia Hypomagnesemia Hypophosphatemia Injection site sequelae Tachycardia |
The following precautions are available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
Embryofetal development studies in mice and rats using ceftolozane dosages associated with exposures approximately 7 and 4 times, respectively, the exposure expected in humans receiving a ceftolozane dosage of 1 g three times daily did not reveal evidence of fetal toxicity. In a study in rats, ceftolozane administered during pregnancy and lactation was associated with decreased auditory startle response in male pups at postnatal day 60. Embryofetal development studies in rats using tazobactam dosages approximately 19 times the recommended human dosage revealed evidence of maternal toxicity (decreased food consumption and body weight gain), but no evidence of fetal toxicity.
In a study in rats, tazobactam administered during pregnancy and lactation in dosages approximately 8 times the recommended human dosage produced decreased maternal food consumption and body weight gain at the end of gestation and an increased incidence of stillbirths. Although pups of dams receiving tazobactam in dosages of 320-1280 mg/kg daily had substantially reduced postnatal body weight at 21 days after delivery, there was no evidence of effects on development, function, learning, or fertility of the pups. There are no adequate and controlled studies using ceftolozane and tazobactam in pregnant women, and the drug should be used during pregnancy only if potential benefits to the woman justify potential risks to the fetus.
In a study in rats, tazobactam administered during pregnancy and lactation in dosages approximately 8 times the recommended human dosage produced decreased maternal food consumption and body weight gain at the end of gestation and an increased incidence of stillbirths. Although pups of dams receiving tazobactam in dosages of 320-1280 mg/kg daily had substantially reduced postnatal body weight at 21 days after delivery, there was no evidence of effects on development, function, learning, or fertility of the pups. There are no adequate and controlled studies using ceftolozane and tazobactam in pregnant women, and the drug should be used during pregnancy only if potential benefits to the woman justify potential risks to the fetus.
Because it is not known whether ceftolozane or tazobactam is distributed into human milk, the fixed combination of ceftolozane and tazobactam should be used with caution in nursing women.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for ZERBAXA (ceftolozane sulfate/tazobactam sodium):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for ZERBAXA (ceftolozane sulfate/tazobactam sodium)'s list of indications:
Bacteroides complicated appendicitis | |
B96.6 | Bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Complicated appendicitis | |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.890 | Other acute appendicitis without perforation or gangrene |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Complicated bacterial infection of urinary tract | |
N39.0 | Urinary tract infection, site not specified |
O23.0 | Infections of kidney in pregnancy |
O23.00 | Infections of kidney in pregnancy, unspecified trimester |
O23.01 | Infections of kidney in pregnancy, first trimester |
O23.02 | Infections of kidney in pregnancy, second trimester |
O23.03 | Infections of kidney in pregnancy, third trimester |
O23.1 | Infections of bladder in pregnancy |
O23.10 | Infections of bladder in pregnancy, unspecified trimester |
O23.11 | Infections of bladder in pregnancy, first trimester |
O23.12 | Infections of bladder in pregnancy, second trimester |
O23.13 | Infections of bladder in pregnancy, third trimester |
O23.2 | Infections of urethra in pregnancy |
O23.20 | Infections of urethra in pregnancy, unspecified trimester |
O23.21 | Infections of urethra in pregnancy, first trimester |
O23.22 | Infections of urethra in pregnancy, second trimester |
O23.23 | Infections of urethra in pregnancy, third trimester |
O23.3 | Infections of other parts of urinary tract in pregnancy |
O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
O23.4 | Unspecified infection of urinary tract in pregnancy |
O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.51 | Infection and inflammatory reaction due to urinary catheter |
T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
T83.518 | Infection and inflammatory reaction due to other urinary catheter |
T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
T83.593 | Infection and inflammatory reaction due to other urinary stents |
T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
Complicated bacterial peritonitis | |
B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated bacteroides peritonitis | |
B96.6 | Bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated e. coli peritonitis | |
B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated e. coli UTI | |
B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
N39.0 | Urinary tract infection, site not specified |
O23.0 | Infections of kidney in pregnancy |
O23.00 | Infections of kidney in pregnancy, unspecified trimester |
O23.01 | Infections of kidney in pregnancy, first trimester |
O23.02 | Infections of kidney in pregnancy, second trimester |
O23.03 | Infections of kidney in pregnancy, third trimester |
O23.1 | Infections of bladder in pregnancy |
O23.10 | Infections of bladder in pregnancy, unspecified trimester |
O23.11 | Infections of bladder in pregnancy, first trimester |
O23.12 | Infections of bladder in pregnancy, second trimester |
O23.13 | Infections of bladder in pregnancy, third trimester |
O23.2 | Infections of urethra in pregnancy |
O23.20 | Infections of urethra in pregnancy, unspecified trimester |
O23.21 | Infections of urethra in pregnancy, first trimester |
O23.22 | Infections of urethra in pregnancy, second trimester |
O23.23 | Infections of urethra in pregnancy, third trimester |
O23.3 | Infections of other parts of urinary tract in pregnancy |
O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
O23.4 | Unspecified infection of urinary tract in pregnancy |
O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.51 | Infection and inflammatory reaction due to urinary catheter |
T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
T83.518 | Infection and inflammatory reaction due to other urinary catheter |
T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
T83.593 | Infection and inflammatory reaction due to other urinary stents |
T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
Complicated enterobacter peritonitis | |
B96.89 | Other specified bacterial agents as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated klebsiella peritonitis | |
B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated proteus peritonitis | |
B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated proteus UTI | |
B96.4 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
N39.0 | Urinary tract infection, site not specified |
O23.0 | Infections of kidney in pregnancy |
O23.00 | Infections of kidney in pregnancy, unspecified trimester |
O23.01 | Infections of kidney in pregnancy, first trimester |
O23.02 | Infections of kidney in pregnancy, second trimester |
O23.03 | Infections of kidney in pregnancy, third trimester |
O23.1 | Infections of bladder in pregnancy |
O23.10 | Infections of bladder in pregnancy, unspecified trimester |
O23.11 | Infections of bladder in pregnancy, first trimester |
O23.12 | Infections of bladder in pregnancy, second trimester |
O23.13 | Infections of bladder in pregnancy, third trimester |
O23.2 | Infections of urethra in pregnancy |
O23.20 | Infections of urethra in pregnancy, unspecified trimester |
O23.21 | Infections of urethra in pregnancy, first trimester |
O23.22 | Infections of urethra in pregnancy, second trimester |
O23.23 | Infections of urethra in pregnancy, third trimester |
O23.3 | Infections of other parts of urinary tract in pregnancy |
O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
O23.4 | Unspecified infection of urinary tract in pregnancy |
O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.51 | Infection and inflammatory reaction due to urinary catheter |
T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
T83.518 | Infection and inflammatory reaction due to other urinary catheter |
T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
T83.593 | Infection and inflammatory reaction due to other urinary stents |
T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
Complicated pseudomonas aeruginosa peritonitis | |
B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated streptococcus peritonitis | |
B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
B95.1 | Streptococcus, group b, as the cause of diseases classified elsewhere |
B95.3 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
B95.4 | Other streptococcus as the cause of diseases classified elsewhere |
B95.5 | Unspecified streptococcus as the cause of diseases classified elsewhere |
K65.0 | Generalized (acute) peritonitis |
K65.2 | Spontaneous bacterial peritonitis |
T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Complicated UTI with pseudomonas aeruginosa | |
B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
N39.0 | Urinary tract infection, site not specified |
O23.0 | Infections of kidney in pregnancy |
O23.00 | Infections of kidney in pregnancy, unspecified trimester |
O23.01 | Infections of kidney in pregnancy, first trimester |
O23.02 | Infections of kidney in pregnancy, second trimester |
O23.03 | Infections of kidney in pregnancy, third trimester |
O23.1 | Infections of bladder in pregnancy |
O23.10 | Infections of bladder in pregnancy, unspecified trimester |
O23.11 | Infections of bladder in pregnancy, first trimester |
O23.12 | Infections of bladder in pregnancy, second trimester |
O23.13 | Infections of bladder in pregnancy, third trimester |
O23.2 | Infections of urethra in pregnancy |
O23.20 | Infections of urethra in pregnancy, unspecified trimester |
O23.21 | Infections of urethra in pregnancy, first trimester |
O23.22 | Infections of urethra in pregnancy, second trimester |
O23.23 | Infections of urethra in pregnancy, third trimester |
O23.3 | Infections of other parts of urinary tract in pregnancy |
O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
O23.4 | Unspecified infection of urinary tract in pregnancy |
O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.51 | Infection and inflammatory reaction due to urinary catheter |
T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
T83.518 | Infection and inflammatory reaction due to other urinary catheter |
T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
T83.593 | Infection and inflammatory reaction due to other urinary stents |
T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
Diverticulitis of gastrointestinal tract | |
K57.0 | Diverticulitis of small intestine with perforation and abscess |
K57.00 | Diverticulitis of small intestine with perforation and abscess without bleeding |
K57.01 | Diverticulitis of small intestine with perforation and abscess with bleeding |
K57.12 | Diverticulitis of small intestine without perforation or abscess without bleeding |
K57.13 | Diverticulitis of small intestine without perforation or abscess with bleeding |
K57.2 | Diverticulitis of large intestine with perforation and abscess |
K57.20 | Diverticulitis of large intestine with perforation and abscess without bleeding |
K57.21 | Diverticulitis of large intestine with perforation and abscess with bleeding |
K57.32 | Diverticulitis of large intestine without perforation or abscess without bleeding |
K57.33 | Diverticulitis of large intestine without perforation or abscess with bleeding |
K57.4 | Diverticulitis of both small and large intestine with perforation and abscess |
K57.40 | Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
K57.41 | Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
K57.52 | Diverticulitis of both small and large intestine without perforation or abscess without bleeding |
K57.53 | Diverticulitis of both small and large intestine without perforation or abscess with bleeding |
K57.8 | Diverticulitis of intestine, part unspecified, with perforation and abscess |
K57.80 | Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
K57.81 | Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
K57.92 | Diverticulitis of intestine, part unspecified, without perforation or abscess without bleeding |
K57.93 | Diverticulitis of intestine, part unspecified, without perforation or abscess with bleeding |
E. coli complicated appendicitis | |
B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Intra-abdominal abscess | |
D73.3 | Abscess of spleen |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K50.014 | Crohn's disease of small intestine with abscess |
K50.114 | Crohn's disease of large intestine with abscess |
K50.814 | Crohn's disease of both small and large intestine with abscess |
K50.914 | Crohn's disease, unspecified, with abscess |
K51.014 | Ulcerative (chronic) pancolitis with abscess |
K51.214 | Ulcerative (chronic) proctitis with abscess |
K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
K51.414 | Inflammatory polyps of colon with abscess |
K51.514 | Left sided colitis with abscess |
K51.814 | Other ulcerative colitis with abscess |
K51.914 | Ulcerative colitis, unspecified with abscess |
K57.0 | Diverticulitis of small intestine with perforation and abscess |
K57.00 | Diverticulitis of small intestine with perforation and abscess without bleeding |
K57.01 | Diverticulitis of small intestine with perforation and abscess with bleeding |
K57.2 | Diverticulitis of large intestine with perforation and abscess |
K57.20 | Diverticulitis of large intestine with perforation and abscess without bleeding |
K57.21 | Diverticulitis of large intestine with perforation and abscess with bleeding |
K57.4 | Diverticulitis of both small and large intestine with perforation and abscess |
K57.40 | Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
K57.41 | Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
K57.8 | Diverticulitis of intestine, part unspecified, with perforation and abscess |
K57.80 | Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
K57.81 | Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
K63.0 | Abscess of intestine |
K65.1 | Peritoneal abscess |
K68.1 | Retroperitoneal abscess |
K68.11 | Postprocedural retroperitoneal abscess |
K68.12 | Psoas muscle abscess |
K68.19 | Other retroperitoneal abscess |
K75.0 | Abscess of liver |
N15.1 | Renal and perinephric abscess |
N34.0 | Urethral abscess |
N41.2 | Abscess of prostate |
Intra-abdominal bacteroides abscess | |
B96.6 | Bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere |
D73.3 | Abscess of spleen |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K50.014 | Crohn's disease of small intestine with abscess |
K50.114 | Crohn's disease of large intestine with abscess |
K50.814 | Crohn's disease of both small and large intestine with abscess |
K50.914 | Crohn's disease, unspecified, with abscess |
K51.014 | Ulcerative (chronic) pancolitis with abscess |
K51.214 | Ulcerative (chronic) proctitis with abscess |
K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
K51.414 | Inflammatory polyps of colon with abscess |
K51.514 | Left sided colitis with abscess |
K51.814 | Other ulcerative colitis with abscess |
K51.914 | Ulcerative colitis, unspecified with abscess |
K57.0 | Diverticulitis of small intestine with perforation and abscess |
K57.00 | Diverticulitis of small intestine with perforation and abscess without bleeding |
K57.01 | Diverticulitis of small intestine with perforation and abscess with bleeding |
K57.2 | Diverticulitis of large intestine with perforation and abscess |
K57.20 | Diverticulitis of large intestine with perforation and abscess without bleeding |
K57.21 | Diverticulitis of large intestine with perforation and abscess with bleeding |
K57.4 | Diverticulitis of both small and large intestine with perforation and abscess |
K57.40 | Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
K57.41 | Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
K57.8 | Diverticulitis of intestine, part unspecified, with perforation and abscess |
K57.80 | Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
K57.81 | Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
K63.0 | Abscess of intestine |
K65.1 | Peritoneal abscess |
K68.1 | Retroperitoneal abscess |
K68.11 | Postprocedural retroperitoneal abscess |
K68.12 | Psoas muscle abscess |
K68.19 | Other retroperitoneal abscess |
K75.0 | Abscess of liver |
N15.1 | Renal and perinephric abscess |
N34.0 | Urethral abscess |
N41.2 | Abscess of prostate |
Intra-abdominal e. coli abscess | |
B96.2 | Escherichia coli [e. coli ] as the cause of diseases classified elsewhere |
B96.20 | Unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere |
B96.29 | Other escherichia coli [e. coli] as the cause of diseases classified elsewhere |
D73.3 | Abscess of spleen |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K50.014 | Crohn's disease of small intestine with abscess |
K50.114 | Crohn's disease of large intestine with abscess |
K50.814 | Crohn's disease of both small and large intestine with abscess |
K50.914 | Crohn's disease, unspecified, with abscess |
K51.014 | Ulcerative (chronic) pancolitis with abscess |
K51.214 | Ulcerative (chronic) proctitis with abscess |
K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
K51.414 | Inflammatory polyps of colon with abscess |
K51.514 | Left sided colitis with abscess |
K51.814 | Other ulcerative colitis with abscess |
K51.914 | Ulcerative colitis, unspecified with abscess |
K57.0 | Diverticulitis of small intestine with perforation and abscess |
K57.00 | Diverticulitis of small intestine with perforation and abscess without bleeding |
K57.01 | Diverticulitis of small intestine with perforation and abscess with bleeding |
K57.2 | Diverticulitis of large intestine with perforation and abscess |
K57.20 | Diverticulitis of large intestine with perforation and abscess without bleeding |
K57.21 | Diverticulitis of large intestine with perforation and abscess with bleeding |
K57.4 | Diverticulitis of both small and large intestine with perforation and abscess |
K57.40 | Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
K57.41 | Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
K57.8 | Diverticulitis of intestine, part unspecified, with perforation and abscess |
K57.80 | Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
K57.81 | Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
K63.0 | Abscess of intestine |
K65.1 | Peritoneal abscess |
K68.1 | Retroperitoneal abscess |
K68.11 | Postprocedural retroperitoneal abscess |
K68.12 | Psoas muscle abscess |
K68.19 | Other retroperitoneal abscess |
K75.0 | Abscess of liver |
N15.1 | Renal and perinephric abscess |
N34.0 | Urethral abscess |
N41.2 | Abscess of prostate |
Intra-abdominal klebsiella abscess | |
B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
D73.3 | Abscess of spleen |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K50.014 | Crohn's disease of small intestine with abscess |
K50.114 | Crohn's disease of large intestine with abscess |
K50.814 | Crohn's disease of both small and large intestine with abscess |
K50.914 | Crohn's disease, unspecified, with abscess |
K51.014 | Ulcerative (chronic) pancolitis with abscess |
K51.214 | Ulcerative (chronic) proctitis with abscess |
K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
K51.414 | Inflammatory polyps of colon with abscess |
K51.514 | Left sided colitis with abscess |
K51.814 | Other ulcerative colitis with abscess |
K51.914 | Ulcerative colitis, unspecified with abscess |
K57.0 | Diverticulitis of small intestine with perforation and abscess |
K57.00 | Diverticulitis of small intestine with perforation and abscess without bleeding |
K57.01 | Diverticulitis of small intestine with perforation and abscess with bleeding |
K57.2 | Diverticulitis of large intestine with perforation and abscess |
K57.20 | Diverticulitis of large intestine with perforation and abscess without bleeding |
K57.21 | Diverticulitis of large intestine with perforation and abscess with bleeding |
K57.4 | Diverticulitis of both small and large intestine with perforation and abscess |
K57.40 | Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
K57.41 | Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
K57.8 | Diverticulitis of intestine, part unspecified, with perforation and abscess |
K57.80 | Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
K57.81 | Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
K63.0 | Abscess of intestine |
K65.1 | Peritoneal abscess |
K68.1 | Retroperitoneal abscess |
K68.11 | Postprocedural retroperitoneal abscess |
K68.12 | Psoas muscle abscess |
K68.19 | Other retroperitoneal abscess |
K75.0 | Abscess of liver |
N15.1 | Renal and perinephric abscess |
N34.0 | Urethral abscess |
N41.2 | Abscess of prostate |
Klebsiella complicated appendicitis | |
B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Klebsiella complicated UTI | |
B96.1 | Klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere |
N39.0 | Urinary tract infection, site not specified |
O23.0 | Infections of kidney in pregnancy |
O23.00 | Infections of kidney in pregnancy, unspecified trimester |
O23.01 | Infections of kidney in pregnancy, first trimester |
O23.02 | Infections of kidney in pregnancy, second trimester |
O23.03 | Infections of kidney in pregnancy, third trimester |
O23.1 | Infections of bladder in pregnancy |
O23.10 | Infections of bladder in pregnancy, unspecified trimester |
O23.11 | Infections of bladder in pregnancy, first trimester |
O23.12 | Infections of bladder in pregnancy, second trimester |
O23.13 | Infections of bladder in pregnancy, third trimester |
O23.2 | Infections of urethra in pregnancy |
O23.20 | Infections of urethra in pregnancy, unspecified trimester |
O23.21 | Infections of urethra in pregnancy, first trimester |
O23.22 | Infections of urethra in pregnancy, second trimester |
O23.23 | Infections of urethra in pregnancy, third trimester |
O23.3 | Infections of other parts of urinary tract in pregnancy |
O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
O23.4 | Unspecified infection of urinary tract in pregnancy |
O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.51 | Infection and inflammatory reaction due to urinary catheter |
T83.510 | Infection and inflammatory reaction due to cystostomy catheter |
T83.510A | Infection and inflammatory reaction due to cystostomy catheter, initial encounter |
T83.511 | Infection and inflammatory reaction due to indwelling urethral catheter |
T83.511A | Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter |
T83.512 | Infection and inflammatory reaction due to nephrostomy catheter |
T83.512A | Infection and inflammatory reaction due to nephrostomy catheter, initial encounter |
T83.518 | Infection and inflammatory reaction due to other urinary catheter |
T83.518A | Infection and inflammatory reaction due to other urinary catheter, initial encounter |
T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
T83.590 | Infection and inflammatory reaction due to implanted urinary neurostimulation device |
T83.590A | Infection and inflammatory reaction due to implanted urinary neurostimulation device, initial encounter |
T83.591 | Infection and inflammatory reaction due to implanted urinary sphincter |
T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter |
T83.592 | Infection and inflammatory reaction due to indwelling ureteral stent |
T83.592A | Infection and inflammatory reaction due to indwelling ureteral stent, initial encounter |
T83.593 | Infection and inflammatory reaction due to other urinary stents |
T83.593A | Infection and inflammatory reaction due to other urinary stents, initial encounter |
T83.598 | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system |
T83.598A | Infection and inflammatory reaction due to other prosthetic device, implant and graft in urinary system, initial encounter |
Nosocomial bacterial pneumonia | |
J95.851 | Ventilator associated pneumonia |
Pseudomonas aeruginosa complicated appendicitis | |
B96.5 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Streptococcus complicated appendicitis | |
B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
B95.1 | Streptococcus, group b, as the cause of diseases classified elsewhere |
B95.3 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
B95.4 | Other streptococcus as the cause of diseases classified elsewhere |
B95.5 | Unspecified streptococcus as the cause of diseases classified elsewhere |
K35 | Acute appendicitis |
K35.2 | Acute appendicitis with generalized peritonitis |
K35.20 | Acute appendicitis with generalized peritonitis, without abscess |
K35.201 | Acute appendicitis with generalized peritonitis, with perforation, without abscess |
K35.21 | Acute appendicitis with generalized peritonitis, with abscess |
K35.210 | Acute appendicitis with generalized peritonitis, without perforation, with abscess |
K35.211 | Acute appendicitis with generalized peritonitis, with perforation and abscess |
K35.219 | Acute appendicitis with generalized peritonitis, with abscess, unspecified as to perforation |
K35.3 | Acute appendicitis with localized peritonitis |
K35.30 | Acute appendicitis with localized peritonitis, without perforation or gangrene |
K35.31 | Acute appendicitis with localized peritonitis and gangrene, without perforation |
K35.32 | Acute appendicitis with perforation, localized peritonitis, and gangrene, without abscess |
K35.33 | Acute appendicitis with perforation, localized peritonitis, and gangrene, with abscess |
K35.8 | Other and unspecified acute appendicitis |
K35.80 | Unspecified acute appendicitis |
K35.89 | Other acute appendicitis |
K35.891 | Other acute appendicitis without perforation, with gangrene |
K36 | Other appendicitis |
K37 | Unspecified appendicitis |
Ventilator-associated bacterial pneumonia | |
J95.851 | Ventilator associated pneumonia |
Formulary Reference Tool